Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    8 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.3.3 has been added to the page footer, and HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:43:08.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page history shows a new Revision: v3.3.2 replacing v3.3.1. No substantive changes to the study record or visible content are shown.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:55.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the page footer.
    Difference
    0.0%
    Check dated 2025-11-24T13:20:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The funding/operating status notice was removed from the page; the rest of the record history and trial details remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:28:42.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The Record History page displays a redesigned layout and updated styling for the version list, while the underlying version data remains unchanged.
    Difference
    0.0%
    Check dated 2025-11-03T01:10:22.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    8%
    Check dated 2025-10-05T09:29:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.